• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.64% Nasdaq Down 0.55%

    Idera Pharmaceuticals, Inc. (IDRA)

    -NasdaqCM
    3.84 Up 0.24(6.67%) May 29, 4:00PM EDT
    |After Hours : 3.85 Up 0.01 (0.26%) May 29, 4:40PM EDT
    Add to Portfolio
    Prev Close:3.60
    Open:3.61
    Bid:3.00 x 1600
    Ask:4.37 x 600
    1y Target Est:7.00
    Beta:2.59
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:3.54 - 3.85
    52wk Range:1.94 - 5.48
    Volume:2,512,189
    Avg Vol (3m):1,918,960
    Market Cap:452.64M
    P/E (ttm):N/A
    EPS (ttm):-0.47
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IDRAUp 6.67%452.64M
    DVAXUp 1.16%667.23M
    PFEUp 0.90%213.98B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4,080.29
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.45
    Quarterly EPS Est (Jun-15) :-0.11
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback